Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Cardiovascular Diabetology|January 30, 2019
Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort studyZheng Qin, Kuo Zhou, Yue-Ping Li, et al.Journal of Cancer|November 28, 2019
CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patientsLi-Ming Tan, Xi Li, Cheng-Feng Qiu, et al.Oncotarget|August 11, 2016
PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literatureJian Xiao, Cheng-Ping Hu, Bi-Xiu He, et al.Respiratory Medicine|November 28, 2016
IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesityJian-Hui Chen, Ling Qin, Ying-Ying Shi, et al.Oncotargets and Therapy|December 22, 2018
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lungShun Lu, Wei Li, Caicun Zhou, et al.Biological Chemistry|December 22, 2016
Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1Jian-Hui Chen, Yu-Long Zheng, Chuan-Qin Xu, et al.Cancer Biology & Therapy|August 2, 2018
Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinomaMin Li, Bing-Rong Zhao, Shi-Qing Liu, et al.Oncotargets and Therapy|December 26, 2018
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trialYi-Long Wu, Chong-Rui Xu, Cheng-Ping Hu, et al.Scientific Data|December 12, 2018
Gene-gene and gene-environment interaction data for platinum-based chemotherapy in non-small cell lung cancerLei-Yun Wang, Jia-Jia Cui, Jun-Yan Liu, et al.Trials|September 25, 2015
Efficacy of acupuncture for chronic asthma: study protocol for a randomized controlled trialLei-Miao Yin, Yu Wang, Lei Fan, et al.Pageof 10